Article citationsMore>>
McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Bohm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M.A., Jaarsma, T., Kober, L., Lip, G.Y., Maggioni, A.P., Parkhomenko, A., Pieske, B.M., Popescu, B.A., Ronnevik, P.K., Rutten, F.H., Schwitter, J., Seferovic, P., Stepinska, J., Trindade, P.T., Voors, A.A., Zannad, F., Zeiher, A. Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: Bax, J.J., Baumgartner, H., Ceconi, C., Dean, V., Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Kirchhof, P., Knuuti, J., Kolh, P., McDonagh, T., Moulin, C., Popescu, B.A., Reiner, Z., Sechtem, U., Sirnes, P.A., Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh, T., Sechtem, U., Bonet, L.A., Avraamides, P., Ben Lamin, H.A., Brignole, M., Coca, A., Cowburn, P., Dargie, H., Elliott, P., Flachskampf, F.A., Guida, G.F., Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen, O.W., Orn, S., Parissis, J.T., Ponikowski, P. and ESC Committee for Practice Guidelines (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 14, 803-869. doi:10.1093/eurjhf/hfs105
has been cited by the following article:
-
TITLE:
The pathophysiology of AHF—New insights from recent studies of novel diuretics and vascular modulating therapies
AUTHORS:
Gad Cotter, Olga Milo, Beth Davison
KEYWORDS:
Heart Failure; Treatment; Novel
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.3 No.1A,
March
27,
2013
ABSTRACT: Treatment of chronic congestive heart failure (HF) has improved substantially during the past decades, with the introduction of modulators of the renin angiotensin aldosterone system (RAAS) such as angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs) and aldosterone antagonists and the introduction of the lifesaving beta-blockers as well as device therapy. Despite the dramatic improvement in the treatment of chronic HF, no such progress was achieved in the treatment of acute heart failure (AHF). Diuretics that were never rigorously examined in well controlled large prospective randomized studies remain the cornerstone and almost exclusively the only intravenous therapeutic option for AHF and no further effective therapy as introduced in more than 30 years. As a result, the short term morbidity and most importantly mortality of AHF remains extremely high with up to 20% of patients dying in the first months after admission for AHF and an additional 20% being readmitted to the hospital. In the current manuscript we will address the practical concerns regarding established and novel diuretic and vascular modulating therapies in patients with AHF, examine their recommended use and seek to determine a path to developing better and more effective therapies for AHF.
Related Articles:
-
Shuo Zhang, Jiaying Wang, Hongcai Shang
-
Tony Abdel Massih, Hadi Skouri, Antoine Sarkis, Malek Mohammad, Abbas Alaaeddine, Jean Paul Sahakian, James Januzzi
-
Assétou Soukho Kaya, Abdel Kader Traoré, Djibril Sy, Djenebou Traoré, Ilo Diall, Youssouf Fofana, Ibahima Amadou Dembélé, Boua Daoud Camara, Mamadou Saliou, Karim Dao, Mamadou Cissoko, Kaly Kéïta, Barry Boubacar Sangaré, Mamadou Mallé, Alassane A. Doumbia, Hadiza A. Kaïlou, Mamadou Dembélé, Hamar Alassane Traoré
-
Camara Youssouf, Ba Hamidou Oumar, Sangare Ibrahima, Toure Karamba, Coulibaly Souleymane, Sacko Abdoul Karim, Coulibaly Alfousseyni, Diallo Nouhoum, Sidibe Samba, Daou Adama, Menta Ichaka, Diall Ilo Bella, Diallo Boubakar Abdoulaye
-
Haruka Otsu, Toshiko Inoguchi, Michiko Moriyama, Shigeko Takayama, Yoko Watanabe, Masayo Kume